OESTRA

Serial Number 98966522
Registration 8098995
700

Registration Progress

Application Filed
Jan 15, 2025
Under Examination
Approved for Publication
Nov 25, 2025
Published for Opposition
Nov 25, 2025
Registered
Jan 13, 2026

Trademark Image

OESTRA

Basic Information

Serial Number
98966522
Registration Number
8098995
Filing Date
January 15, 2025
Registration Date
January 13, 2026
Published for Opposition
November 25, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Jan 13, 2026
Registration
Registered
Classes
005

Rights Holder

Inner Balance, LLC

16
Address
827 E Park Blvd
Suite 200
Boise, ID 83712

Ownership History

Inner Balance, LLC

Original Applicant
16
Boise, ID

Inner Balance, LLC

Owner at Publication
16
Boise, ID

Inner Balance, LLC

Original Registrant
16
Boise, ID

Legal Representation

Attorney
Jason M. Rhodes

USPTO Deadlines

Next Deadline
2174 days remaining
Section 8 Declaration Due (Principal Register)
Due Date
January 13, 2032
Grace Period Ends
July 13, 2032

Application History

15 events
Date Code Type Description Documents
Jan 13, 2026 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Jan 13, 2026 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Nov 25, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Nov 25, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 19, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Oct 23, 2025 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 30, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Sep 30, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Sep 30, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jun 30, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jun 30, 2025 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jun 30, 2025 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jun 25, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 16, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 15, 2025 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Medicated prescription vaginal hormone preparation for treatment of perimenopause, menopause, endometriosis, Polycystic Ovary Syndrome (PCOS), cysts, fibroids, and Premenstrual Dysphoric Disorder (PMDD); medicated, bio-identical estradiol and progesterone hormone replacement therapy preparation in the form of a vaginal cream.
First Use Anywhere: Feb 1, 2024
First Use in Commerce: Feb 1, 2024

Classification

International Classes
005